齊翔騰達(002408.SZ):目前盈利的產品有叔丁醇、異丁烯、甲乙酮、丙烯酸、仲丁醇、橡膠等
格隆匯5月22日丨齊翔騰達(002408.SZ)於近期投資者關係活動表示,公司目前盈利的產品有叔丁醇、異丁烯、甲乙酮、丙烯酸、仲丁醇、橡膠等。一季度受下遊需求偏弱等因素影響,公司業績同比下滑,隨着貿易戰的緩和,疊加原料價格下降等因素,公司將在確保安全生產的前提下,向內進一步深挖內潛,向外努力抓好產品銷售和出口業務,確保全年各項目標任務的順利實現。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.